{"abstract": "The drug, Praluent, developed by Sanofi and Regeneron, is expected to become the next flashpoint in the growing controversy of escalating pharmaceutical price.", "web_url": "https://www.nytimes.com/2015/07/25/business/us-approves-drug-that-can-sharply-lower-cholesterol-levels.html", "snippet": "The drug, Praluent, developed by Sanofi and Regeneron, is expected to become the next flashpoint in the growing controversy of escalating pharmaceutical price.", "lead_paragraph": "Federal regulators on Friday approved the first of a new class of drug that can sharply lower cholesterol levels, offering a new option for millions of Americans suffering from cardiovascular disease, the nation\u2019s leading killer.", "print_section": "B", "print_page": "1", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2015/07/25/business/25drug-web/25drug-web-articleLarge.jpg", "height": 400, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2015/07/25/business/25drug-web/25drug-web-articleLarge.jpg", "xlargewidth": 600, "xlargeheight": 400}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2015/07/25/business/25drug-web/25drug-web-jumbo.jpg", "height": 683, "width": 1024, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2015/07/25/business/25drug-web/25drug-web-superJumbo.jpg", "height": 1366, "width": 2048, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2015/07/25/business/25drug-web/25drug-web-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2015/07/25/business/25drug-web/25drug-web-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2015/07/25/business/25drug-web/25drug-web-thumbLarge.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "New Drug Sharply Lowers Cholesterol, but It\u2019s Costly", "kicker": null, "content_kicker": null, "print_headline": "New Drug Sharply Lowers Cholesterol, but It&#8217;s Costly ", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "persons", "value": "Pollack, Andrew", "rank": 1, "major": "N"}, {"name": "subject", "value": "Praluent (Drug)", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Regeneron Pharmaceuticals Inc", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Sanofi SA", "rank": 4, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 5, "major": "N"}, {"name": "subject", "value": "Cholesterol", "rank": 6, "major": "N"}, {"name": "organizations", "value": "Food and Drug Administration", "rank": 7, "major": "N"}], "pub_date": "2015-07-24T18:33:00+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Andrew Pollack", "person": [{"firstname": "Andrew", "middlename": null, "lastname": "Pollack", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/12d0557b-5aaf-50da-af56-f9b77e4c15e6", "word_count": 1294, "uri": "nyt://article/12d0557b-5aaf-50da-af56-f9b77e4c15e6"}